A growing shortage of critical chemotherapy medicines is beginning to impact cancer treatment across India, with hospitals reporting dwindling inventories and patients struggling to access life-saving drugs. Oncologists and healthcare providers have warned that prolonged supply disruptions could affect treatment schedules and potentially compromise outcomes
In a significant administrative move, the Centre has appointed women directors to lead three major government hospitals in New Delhi, marking an important step towards increasing women’s representation in senior healthcare leadership roles across India’s public health system. Officials said the appointments reflect the government’s growing
As the pharmaceutical, nutraceutical, and herbal wellness industries continue to witness rapid growth, the need for dependable and quality driven supply partners has become more crucial than ever. In this evolving business landscape, Star Bio Pharma has emerged as a growing force in the domain of B2B pharmaceutical
First Marketing Authorization secured by Venus Remedies for Plerixafor in any market Advances the company's shift into higher value specialty injectables across regulated markets Plerixafor is a stem cell mobilization therapy used in autologous transplantation for multiple myeloma and non-Hodgkin lymphoma Venus Remedies Limited (NSE:
India and the Netherlands have expanded bilateral cooperation in the healthcare, pharmaceutical, biotechnology, and medical technology sectors as part of the broader “Roadmap of India-Netherlands Strategic Partnership,” aimed at accelerating innovation, healthcare infrastructure development, research collaboration, and sustainable medical manufacturing. The latest development follows high-level bilateral
Approval marks Venus Remedies’ entry into Argentina for Ceftriaxone, taking total global MAs for the antibiotic to 39 Argentina is the 4th-largest pharmaceutical market in Latin America, valued at approximately US$7.3 billion in 2023 Approval strengthens Venus Remedies’ growing international anti infective portfolio amid rising burden of infectious
Aimed at supporting the growing number of Indian pharmacists aspiring to build careers abroad. The move marks a strategic step toward supporting Indian pharmacy graduates & professionals aiming to build careers abroad, particularly in countries like Australia, Canada, Ireland, New Zealand, & the Middle East. The Hyderabad
India and Japan reinforced their bilateral healthcare collaboration at the 3rd Joint Committee Meeting (JCM) on Healthcare held at Bharat Mandapam. The meeting, held under the India Japan Memorandum of Cooperation in Healthcare and Wellness, was co chaired by Union Health Minister Jagat Prakash Nadda
Global life sciences leader Thermo Fisher Scientific has announced an agreement to sell its microbiology business to European private equity firm Astorg for approximately $1.075 billion. The move is part of Thermo Fisher’s ongoing strategy to streamline its portfolio and focus on high growth, high
Prateek N Kumar, Founder & CEO of NeoNiche, said the project demanded quick alignment & constant adaptation as the team delivered 12 cycle meetings & a Confluence Strategy Meet for more than 1500 industry leaders at Hyatt Regency Gurugram. NeoNiche has detailed how its first assignment
